Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer

Supporting evidence

• Evaluation report

• Appraisal consultation committee papers (TA770) (PDF 1.6 MB)

  Published:

  09 February 2022

• Final appraisal determination committee papers (TA770) (PDF 803 KB)

  Published:

  09 February 2022

• Committee papers (TA600) (PDF 4.9 MB)

  Published:

  11 September 2019